SK Bioscience plans to produce 20 million Novavax shots through September, all of which will be used locally.
News
- Asia Today: India records another surge in COVID-19 cases
- The Latest: UN chief calls for tax on pandemic profiteers
... Novavax has agreed to a licensing arrangement that will allow a South Korean biotech firm to produce its coronavirus vaccines for later this year.
- American, Russians dock at International Space Station
The three will work on hundreds of experiments in biology, biotechnology, physical science and Earth science. On the International Space Station, they ...
- Big moves at BioMedSA: New HQ; event for investors, funding seekers
While San Antonio does not have a true bioscience hub, the move will bring BioMedSA closer to much of that activity. Hanson said the change of ...
- Biden budget seeks more for schools, health care and housing
The administration is also asking for $6.5 billion to establish a biomedical research agency to address cancer, diabetes, Alzheimer's and other ...